Reply to Jain et al

Clin Infect Dis. 2019 Nov 27;69(12):2235-2236. doi: 10.1093/cid/ciz379.

Authors

Farnaz Foolad¹, Roy F Chemaly²

Affiliations

¹ Division of Pharmacy, Infection Control, and Employee Health, University of Texas MD Anderson Cancer Center, Houston.
² Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas MD Anderson Cancer Center, Houston.

PMID: 31074774
DOI: 10.1093/cid/ciz379

No abstract available

Publication types

Letter
Comment

MeSH terms

Hematopoietic Stem Cell Transplantation*
Humans
Respiratory Syncytial Virus Infections*
Ribavirin
Transplant Recipients

Substances

Ribavirin